Stay updated on CDX-585 in Advanced Malignancies Clinical Trial

Sign up to get notified when there's something new on the CDX-585 in Advanced Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CDX-585 in Advanced Malignancies Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a potential update or modification in the context of a clinical trial study involving the PD-1 x ILT4 Bispecific Antibody CDX-585 in patients with advanced malignancies.
    Difference
    0.1%
    Check dated 2024-06-06T14:21:16.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for the study, specifying the types of cancer and other health conditions required for participation. Previously, no information was provided in this section.
    Difference
    21%
    Check dated 2024-05-22T20:30:37.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T21:55:48.000Z thumbnail image

Stay in the know with updates to CDX-585 in Advanced Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CDX-585 in Advanced Malignancies Clinical Trial page.